MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic

    L. Williams, B. Magennis, N. Feerick, T. Lynch (Dublin, Ireland)

  • Validation of a patient/caregiver questionnaire to evaluate nocturnal hypokinesia in Parkinson’s disease

    R. Bhidayasiri, O. Jitkritsadakul, J. Sringean, P. Martinez-Martin, C. Anan, N. Kantachadvanich, R. Chaudhuri, N. Hattori (Bangkok, Thailand)

  • Validation of protein phosphatases that regulate the LRRK2 phosphorylation cycle

    M. Drouyer, M. Emanuele, R. Lefebvre, K. Cailliau-Maggio, A. martoriati, T. Comptdaer, P. Semaille, E. Mutez, W. Sibran, N. Wolkoff, E. Lobbestael, M. Bolliger, V. Baekelandt, J. Nichols, MC. Chartier-Harlin, JM. Taymans (Lille, France)

  • Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

    G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

  • Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)

    V. Luk, N. Cheung, G. Chan, KF. Leung, NFJ. Lui, WW. Wong, I. Chan, C. Li (Kowloon, Hong Kong)

  • Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

    A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

  • Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report

    D. Ciampi-de-Andrade, S. Perez-Lloret, N. Hollenstein, R. Curry, V. Rossetto Barbosa, G. Kägi, S. Hägele-Link, J. Walch, R. Gonzenbach, J-P. Lefaucheur, S. Beer, C. Möller, V. Mylius (Sao Paulo, Brazil)

  • Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients

    H. Çotur Levent, AY. Yılmaz, MC. Akbostancı (Ankara, Turkey)

  • Variable selection using machine-learning to identify new signatures of patient-derived aggregated α-synuclein-induced neurodegeneration in non-human primates

    M. Bourdenx, A. Nioche, S. Dovero, M.L. Arotçarena, S. Camus, G. Porras, M.L. Thiolat, N. Rougier, A. Prigent, P. Aubert, S. Bohic, N. Kruse, B. Mollenhauer, S. Novello, M. Morari, I. Trigo, M. Goillandeau, M. Tasselli, C. Perier, N. Garcia Carrillo, C. Estrada, A. Recasens, J. Blesa, M. Herrero, P. Derkinderen, M. Vila, J. Obeso, B. Dehay, E. Bezard (Bordeaux, France)

  • Variants in MCCC1/LAMP3 and DGKQ Identified Through GWAS are Not Associated with PD in a Malaysian Malay Cohort

    JL. Lim, AH. Tan, SY. Lim, AA. Azlina (Kuala Lumpur, Malaysia)

  • Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease

    V. Pitz, N. Malek, K. Grosset, D. Grosset (Glasgow, United Kingdom)

  • Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease

    C. Simonet, A. Garrido, F. Valldeoriola, MJ. Martí, Y. Compta (Barcelona, Spain)

  • Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study

    A. Velon, M. Mendes, R. Raimundo, R. Jesus, R. Almendra (Vila Real, Portugal)

  • Vertical and horizontal eye movements in a large cohort of early manifest Huntington’s disease: Evidence from ENROLL-HD

    W. Muller, M. MacAskill, L. Paermentier, T. Anderson (Christchurch, New Zealand)

  • Vestibulo-Ocular Reflex Assessment in Patients with Sporadic Ataxia

    H. Teive, B. Zeigelboim, K. Kronbauer, A. Vom Scheidt, R. Santos, N. Mello (Curitiba, Brazil)

  • Visual cueing using laser-shoes reduces freezing of gait in Parkinson patients at home

    C. Barthel, M. van Helvert, R. Haan, A. Janssen, A. Delval, N. de Vries, V. Weerdesteyn, B. Debu, R. van Wezel, B. Bloem, M. Ferraye (Nijmegen, Netherlands)

  • Visual deficits of self-motion perception in Parkinson’s disease

    S. Yakubovich, O. Halperin, S. Hassin, S. Israeli-Korn, A. Zaidel (Ramat Gan, Israel)

  • Visual hallucinations and autonomic burden are inversely associated with physical activity in PD

    J. Hinkle, K. Perepezko, N. Fischer, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

  • Visual impairment and falls in Parkinson’s disease (PD)

    N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

  • VIT-D and Tics Movement Disorder

    N. Gemawat (Mumbai, India)

  • Vitamin B3 and Neurodevelopment in Parkinson’s Disease

    A. Williams, S. Griffin, R. Fricker (Birmingham, United Kingdom)

  • Voluntary suppression of Parkinson’s tremor

    R. Blakemore, M. MacAskill, D. Myall, T. Anderson (Christchurch, New Zealand)

  • Vowel characteristics associated with Parkinson’s disease in Cantonese

    N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

  • VY-AADC01 gene therapy in Parkinson’s disease: Interim results of the on-going Phase 1b PD-1101 trial

    P. Larson, K. Bankiewicz, A. Van Laar, R. Richardson, B. Ravina, A. Kells, B. Boot, A. Martin, M. Thompson, C. Christine (San Francisco, CA, USA)

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley